Vogten A J, Summerskill W H, Gitnick G L, Schalm S W, Smith J L, Murphy B L, Maynard J E
Lancet. 1976 Jul 17;2(7977):126-8. doi: 10.1016/s0140-6736(76)92849-x.
Serial determinations of e antigen and e antibody were made in 20 patients with chronic active liver disease and hepatitis-B surface antigen (HBsAg) or antibody (anti-HBs). The presence of e antigen was associated with failure to clear HBsAg, produce anti-HBs, or respond to treatment with steroids. It is proposed that the presence of the e antigen is associated with impaired host immune responses to hepatitis-B virus infection and a poor prognosis.
对20例慢性活动性肝病患者以及乙肝表面抗原(HBsAg)或抗体(抗-HBs)进行了e抗原和e抗体的系列测定。e抗原的存在与无法清除HBsAg、产生抗-HBs或对类固醇治疗无反应相关。有人提出,e抗原的存在与宿主对乙肝病毒感染的免疫反应受损及预后不良有关。